Trusted Press Release Distribution   Plans | Login    

Briefing Search
Keyword:
Category:

       

    
Author Details
Imarc Group
www.imarcgroup.com/
sales@imarcgroup.com

Bookmark and Share
High Content Screening Market 2021, Industry Analysis, Share, Size, Trends and Forecast Till 2026
According to IMARC Group’s latest report, the global high content screening market exhibited strong growth during 2015-2020. Looking forward, the market is expected to grow at a CAGR of 8.2% during 2021-2026.

BriefingWire.com, 8/19/2021 - High-content screening (HCS), or cellomics, refers to the analytical method that combines automated imaging and quantitative data analysis to evaluate various biochemical and physical characteristics of sample cells. It aids in drug discovery, complex multivariate drug profiling and toxicity studies by utilizing robots, detectors and software to monitor the entire process.

Request Free Sample Report: https://www.imarcgroup.com/high-content-screening-market/requestsample

Market Trends

The key factor driving the global HCS market is the rising cases of chronic diseases like HIV-AIDS, epilepsy, and Parkinson’s diseases, which require intensive treatment. HCS solutions are inexpensive, resource- and time-efficient, and needed for determining the toxicity of chemicals and complex substances in the pharmaceutical industry. Moreover, several leading manufacturers are developing innovative HCS equipment integrated with software platforms and artificial intelligence (AI) systems to enhance the visualization capabilities of the devices. These technological advancements are expected to create a positive outlook for the market in the coming years.

Ask Analyst and Browse Full Report with TOC & List of Figure: https://www.imarcgroup.com/high-content-screening-market

List of Key Companies Covered in this Market Report:

Becton

Dickinson and Company

Bio-Rad Laboratories Inc.

Biotek Instruments Inc.

Danaher Corporation

GE Healthcare

Merck Millipore

Perkinelmer Inc.

Tecan Group Ltd.

Thermo Fisher Scientific

Yokogawa Electric Corporation

The report has segmented the market on the basis of product, formulation, application and geography.

Breakup by Product:

Instruments

Cell Imaging and Analysis Systems

Flow Cytometers

Consumables

Reagents & Assay Kits

Microplates

Other Consumables

Software

Services

Accessories

 

Breakup by Application:

Target Identification and Validation

Primary Screening and Secondary Screening

Toxicity Studies

Compound Profiling

Other Applications

 

Breakup by End-User:

Pharmaceutical and Biotechnology Companies

Academic and Government Institutes

Contract Research Organizations (CROs)

Breakup by Geography:

North America (U.S. & Canada)

Europe (Germany, United Kingdom, France, Italy, Spain, Russia, and Others)

Asia Pacific (China, India, Japan, South Korea, Indonesia, Australia, and Others)

Latin America (Brazil, Mexico)

Middle East & Africa

Key highlights of the report:

Market Performance (2015-2020)

Market Outlook (2021- 2026)

Porter’s Five Forces Analysis

Market Drivers and Success Factors

SWOT Analysis

Value Chain

Comprehensive Mapping of the Competitive Landscape

If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

Contact US

IMARC Group

30 N Gould St Ste R

Sheridan, WY 82801 USA - Wyoming

Email: Sales@imarcgroup.com

Tel No:(D) +91 120 433 0800 Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

 
 
FAQs | Contact Us | Terms & Conditions | Privacy Policy
© 2024 Proserve Technology, Inc.